{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:36:28Z","timestamp":1759412188151},"reference-count":49,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1763,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1750-2659.2010.00177.x","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T20:52:39Z","timestamp":1288990359000},"page":"13-23","source":"Crossref","is-referenced-by-count":16,"title":["Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades"],"prefix":"10.1111","volume":"5","author":[{"given":"Karoline","family":"Bragstad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril J.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joakim S.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars P.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bent","family":"Aasted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Fomsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"issue":"11-12","key":"10.1111\/j.1750-2659.2010.00177.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0264-410X(99)00332-1","article-title":"Prevention and early treatment of influenza in healthy adults","volume":"18","author":"Demicheli","year":"2000","journal-title":"Vaccine"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB2|cit2","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","author":"Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1111\/j.1750-2659.2010.00177.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.molmed.2006.03.007","article-title":"Gene-based vaccines: recent technical and clinical advances","volume":"12","author":"Ulmer","year":"2006","journal-title":"Trends Mol Med"},{"issue":"11","key":"10.1111\/j.1750-2659.2010.00177.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/hum.2006.17.1051","article-title":"DNA vaccines: recent developments and future possibilities","volume":"17","author":"Liu","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1111\/j.1750-2659.2010.00177.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"21","key":"10.1111\/j.1750-2659.2010.00177.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2005.08.012","article-title":"Epidermal DNA vaccine for influenza is immunogenic in humans","volume":"24","author":"Drape","year":"2006","journal-title":"Vaccine"},{"issue":"18","key":"10.1111\/j.1750-2659.2010.00177.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2009.02.061","article-title":"DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial","volume":"27","author":"Jones","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1586\/14760584.7.2.175","article-title":"Current progress of DNA vaccine studies in humans","volume":"7","author":"Lu","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1111\/j.1750-2659.2010.00177.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918-1920 \u201cSpanish\u201d influenza pandemic","volume":"76","author":"Johnson","year":"2002","journal-title":"Bull Hist Med"},{"issue":"5745","key":"10.1111\/j.1750-2659.2010.00177.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1119392","article-title":"Characterization of the reconstructed 1918 spanish influenza pandemic virus","volume":"310","author":"Tumpey","year":"2005","journal-title":"Science"},{"issue":"7212","key":"10.1111\/j.1750-2659.2010.00177.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature07231","article-title":"Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors","volume":"455","author":"Yu","year":"2008","journal-title":"Nature"},{"issue":"10","key":"10.1111\/j.1750-2659.2010.00177.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1600-0463.2006.apm_395.x","article-title":"Immune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1","volume":"114","author":"Vinner","year":"2006","journal-title":"APMIS"},{"issue":"1","key":"10.1111\/j.1750-2659.2010.00177.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/viro.2002.1547","article-title":"Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes","volume":"302","author":"Ljungberg","year":"2002","journal-title":"Virology"},{"issue":"2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.virusres.2004.12.004","article-title":"New avian influenza A virus subtype combination H5N7 identified in Danish mallard ducks","volume":"109","author":"Bragstad","year":"2005","journal-title":"Virus Res"},{"issue":"18","key":"10.1111\/j.1750-2659.2010.00177.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1089\/088922200750054738","article-title":"Construction, biological activity, and immunogenicity of synthetic envelope DNA vaccines based on a primary, CCR5-tropic, early HIV type 1 isolate (BX08) with human codons","volume":"16","author":"Corbet","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0042-6822(64)90212-0","article-title":"Quantitative haemadsorption, a new assay technique. I. Assay and interferon","volume":"24","author":"Finter","year":"1964","journal-title":"Virology"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB17|cit17","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"J Exp Med"},{"issue":"9","key":"10.1111\/j.1750-2659.2010.00177.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/JCM.40.9.3256-3260.2002","article-title":"Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes","volume":"40","author":"Spackman","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"2-4","key":"10.1111\/j.1750-2659.2010.00177.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vetimm.2009.05.011","article-title":"Characterization of antibodies against ferret immunoglobulins, cytokines and CD markers","volume":"132","author":"Martel","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB20|cit20","unstructured":"WHO WHO manual on animal influenza diagnosis and surveillance 2009"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB21|cit21","unstructured":"Gupta R Jung E Brunak S Prediction of N -glycosylation sites in human proteins 2004"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1743-422X-5-40","article-title":"The evolution of human influenza A viruses from 1999 to 2006: a complete genome study","volume":"5","author":"Bragstad","year":"2008","journal-title":"Virol J"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-10-5","article-title":"Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?","volume":"10","author":"Reichert","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"16","key":"10.1111\/j.1750-2659.2010.00177.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1128\/JVI.00769-07","article-title":"N-linked glycosylation attenuates H3N2 influenza viruses","volume":"81","author":"Vigerust","year":"2007","journal-title":"J Virol"},{"issue":"9","key":"10.1111\/j.1750-2659.2010.00177.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/dna.1993.12.799","article-title":"DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates","volume":"12","author":"Wang","year":"1993","journal-title":"DNA Cell Biol"},{"issue":"9","key":"10.1111\/j.1750-2659.2010.00177.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/JVI.02335-08","article-title":"Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus","volume":"83","author":"Laddy","year":"2009","journal-title":"J Virol"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1745-6150-1-34","article-title":"Long intervals of stasis punctuated by bursts of positive selection in the seasonal evolution of influenza A virus","volume":"1","author":"Wolf","year":"2006","journal-title":"Biol Direct"},{"issue":"9","key":"10.1111\/j.1750-2659.2010.00177.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1073\/pnas.0308391100","article-title":"Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus","volume":"101","author":"Tumpey","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1111\/j.1750-2659.2010.00177.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1189\/jlb.68.6.793","article-title":"DNA vaccination: antigen presentation and the induction of immunity","volume":"68","author":"Shedlock","year":"2000","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1111\/j.1750-2659.2010.00177.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"issue":"46-47","key":"10.1111\/j.1750-2659.2010.00177.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"6535","key":"10.1111\/j.1750-2659.2010.00177.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/376092a0","article-title":"Structure of influenza virus haemagglutinin complexed with a neutralizing antibody","volume":"376","author":"Bizebard","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1111\/j.1750-2659.2010.00177.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.63.3.1239-1246.1989","article-title":"Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection","volume":"63","author":"Johansson","year":"1989","journal-title":"J Virol"},{"key":"10.1111\/j.1750-2659.2010.00177.x-BIB34|cit34","first-page":"177","article-title":"Structure and diversity of influenza virus neuraminidase","volume":"114","author":"Colman","year":"1985","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"10.1111\/j.1750-2659.2010.00177.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/S0264-410X(00)00149-3","article-title":"Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase","volume":"18","author":"Chen","year":"2000","journal-title":"Vaccine"},{"issue":"2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"issue":"4","key":"10.1111\/j.1750-2659.2010.00177.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/oxfordjournals.aje.a113441","article-title":"The influenza herald wave","volume":"116","author":"Glezen","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"23","key":"10.1111\/j.1750-2659.2010.00177.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"14933","DOI":"10.1128\/JVI.79.23.14933-14944.2005","article-title":"Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice","volume":"79","author":"Tumpey","year":"2005","journal-title":"J Virol"},{"issue":"2 Pt 1","key":"10.1111\/j.1750-2659.2010.00177.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0092-8674(82)90135-0","article-title":"The antigenic structure of the influenza virus A\/PR\/8\/34 hemagglutinin (H1 subtype)","volume":"31","author":"Caton","year":"1982","journal-title":"Cell"},{"issue":"5","key":"10.1111\/j.1750-2659.2010.00177.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/JVI.71.5.3391-3396.1997","article-title":"Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin","volume":"71","author":"Kodihalli","year":"1997","journal-title":"J Virol"},{"issue":"3","key":"10.1111\/j.1750-2659.2010.00177.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1128\/JVI.73.3.2094-2098.1999","article-title":"DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice","volume":"73","author":"Kodihalli","year":"1999","journal-title":"J Virol"},{"issue":"23","key":"10.1111\/j.1750-2659.2010.00177.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/S0264-410X(99)00485-5","article-title":"Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines","volume":"18","author":"Kodihalli","year":"2000","journal-title":"Vaccine"},{"issue":"1-2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-1702(01)00389-6","article-title":"Importance of hemagglutinin glycosylation for the biological functions of influenza virus","volume":"82","author":"Klenk","year":"2002","journal-title":"Virus Res"},{"issue":"4","key":"10.1111\/j.1750-2659.2010.00177.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.96.4.1651","article-title":"Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene","volume":"96","author":"Reid","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1111\/j.1750-2659.2010.00177.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1111\/j.1750-2659.2010.00177.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4149\/av_2009_01_15","article-title":"Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin","volume":"53","author":"Stropkovska","year":"2009","journal-title":"Acta Virol"},{"issue":"3","key":"10.1111\/j.1750-2659.2010.00177.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"e1000350","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog"},{"issue":"Suppl 2","key":"10.1111\/j.1750-2659.2010.00177.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S0264-410X(02)00136-6","article-title":"Influenza DNA vaccines","volume":"20","author":"Ulmer","year":"2002","journal-title":"Vaccine"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1750-2659.2010.00177.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1750-2659.2010.00177.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T03:53:15Z","timestamp":1685850795000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-2659.2010.00177.x"}},"subtitle":["Immunity by pandemic influenza DNA vaccines"],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1750-2659.2010.00177.x","relation":{},"ISSN":["1750-2640"],"issn-type":[{"value":"1750-2640","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,3]]}}}